Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Clinical trial NCT06660862 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06660862
- Sponsor
- University of Chicago
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2029-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.